About the company
Affimed NV is an innovative clinical-stage biopharmaceutical company dedicated to revolutionizing cancer treatment through the discovery and development of targeted cancer immunotherapies. With a strong emphasis on immuno-oncology, Affimed aims to leverage the power of the body's immune system to effectively combat tumor cells. At the forefront of its research and development efforts, Affimed has an exciting pipeline of product candidates. These candidates offer promising prospects in treating various types of cancer by modulating the patient's immune responses. By identifying and targeting specific immune checkpoints and activating the body's natural defense mechanisms, Affimed's therapies hold the potential to deliver highly precise and effective treatments. The company's commitment to advancing the field of immuno-oncology extends beyond single therapies. Affimed is actively exploring the potential of combination therapies, recognizing that the greatest impact can often be achieved through synergistic approaches. By combining different therapeutic approaches, Affimed aims to enhance treatment outcomes and improve patient responses. Focusing on global impact, Affimed derives a significant portion of its revenue from the United States, reflecting its business presence and partnerships in this key market. Additionally, Affimed has a notable presence in Europe, particularly in Germany, where it continues to strengthen its research and development capabilities. With a team of dedicated scientists and researchers, Affimed continues to push the boundaries of cancer treatment. Through rigorous scientific exploration and advancing technological capabilities, the company is committed to delivering safe and effective therapies to patients in need. By understanding the complexity of the immune system and its relationship with cancer, Affimed is paving the way for a future where cancer can be treated more effectively. In conclusion, Affimed NV is a pioneering biopharmaceutical company that is actively contributing to the field of immuno-oncology. By harnessing the body's immune defenses and developing targeted therapies, Affimed aims to transform cancer treatment and improve patient outcomes. With a strong global presence and an unwavering commitment to scientific excellence, Affimed is poised to make significant contributions to the advancement of cancer immunotherapy.
Website: https://www.affimed.com
Data updated: June 2, 2026
